» Authors » M Lonca

M Lonca

Explore the profile of M Lonca including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 13
Citations 74
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Gonzalez-Cordon A, Domenech M, Camafort M, Martinez-Rebollar M, Torres B, Laguno M, et al.
HIV Med . 2018 May; PMID: 29745457
Objectives: The aim of the study was to assess changes in and factors associated with anatomical [carotid artery intima-media thickness (CIMT)] and functional (arterial stiffness) markers of subclinical cardiovascular disease...
2.
Rojas J, Lonca M, Imaz A, Estrada V, Asensi V, Miralles C, et al.
HIV Med . 2016 Apr; 17(5):340-9. PMID: 27089862
Objective: To assess whether changes in antiretroviral drugs other than thymidine nucleoside reverse transcriptase inhibitors (NRTI) may have a body fat impact in HIV-infected patients with lipoatrophy. Methods: Ninety-six-week phase...
3.
Egana-Gorrono L, Martinez E, Domingo P, Lonca M, Escriba T, Fontdevila J, et al.
Antimicrob Agents Chemother . 2014 Aug; 58(11):6717-23. PMID: 25155608
Gene expression studies of subcutaneous adipose tissue may help to better understand the mechanisms behind body fat changes in HIV-infected patients who initiate antiretroviral therapy (ART). Here, we evaluated early...
4.
Lopez M, Palacio M, Gonce A, Hernandez S, Barranco F, Garcia L, et al.
Eur J Clin Microbiol Infect Dis . 2014 Aug; 34(2):223-30. PMID: 25107626
The purpose of this investigation was to study the risk of intrauterine growth restriction in human immunodeficiency virus (HIV)-infected women and to describe the associated risk factors. A cohort study...
5.
Leon A, Martinez E, Sarasa M, Lopez Y, Mallolas J, de Lazzari E, et al.
J Antimicrob Chemother . 2007 Aug; 60(4):824-30. PMID: 17712031
Objectives: To study the impact of lopinavir/ritonavir-containing therapy on plasma lipids and body fat of HIV-infected adults and to assess whether lopinavir plasma levels at steady state are correlated with...
6.
Martinez E, Milinkovic A, Buira E, de Lazzari E, Leon A, Larrousse M, et al.
HIV Med . 2007 Apr; 8(4):251-8. PMID: 17461853
Background: Since the introduction of highly active antiretroviral therapy (HAART), the incidence of death in HIV-infected patients has dramatically decreased, and causes of death other than those related to HIV...
7.
Coll O, Lopez M, Vidal R, Figueras F, Suy A, Hernandez S, et al.
Reprod Biomed Online . 2007 Apr; 14(4):488-94. PMID: 17425832
The objective of the study was to assess the fertility of non-infertile couples seeking pregnancy in whom the woman was HIV infected. Therefore, a cross-sectional study was conducted between January...
8.
Blanco J, Biglia A, Martinez E, Sanchez M, de Lazzari E, Leon A, et al.
HIV Med . 2006 Apr; 7(4):213-7. PMID: 16630033
Background: The impact of HIV infection or antiretroviral therapy on the intrathoracic fat compartment is unknown. Methods: Consecutive clinically stable HIV-infected adult patients, irrespective of exposure to antiretroviral therapy, and...
9.
Mallolas J, Arrizabalaga J, Lonca M, Gatell J, Adan A, Tortajada C, et al.
AIDS . 1997 Dec; 11(14):1785-7. PMID: 9386819
No abstract available.
10.
Mallolas J, Gatell J, Gomez-Sirvent J, Buira E, Zamora L, Alecrim-Andrade J, et al.
Enferm Infecc Microbiol Clin . 1997 Feb; 15(2):61-4. PMID: 9101748
Background: An approach of daily or 5 days per week treatment as maintenance therapy is mandatory among HIV patients with CMV retinitis. We evaluate the efficacy and tolerance of thrice...